Retail pharmacies can offer abortion pills, FDA says

Norge Nyheter Nyheter

Retail pharmacies can offer abortion pills, FDA says
Norge Siste Nytt,Norge Overskrifter
  • 📰 axios
  • ⏱ Reading Time:
  • 7 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 63%

BREAKING: The Food and Drug Administration made a regulatory change that will make it possible for retail pharmacies to offer abortion pills in the U.S.

The Food and Drug Administration on Tuesday made a regulatory change that will make it possible for retail pharmacies toUnder the regulatory change, certified pharmacies may dispense mifepristone — which is used with misoprostol in first-trimester abortions — directly to patients after receiving a prescription from a certified health provider, according to a statement from Danco Laboratories, one of the makers of the pill.

The FDA has yet to make an announcement, but the agency is expected to update its website to reflect the change later Tuesday.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

axios /  🏆 302. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Here's What a ‘Self-Managed’ Abortion Actually Means and Entails, According to a Certified Nurse MidwifeHere's What a ‘Self-Managed’ Abortion Actually Means and Entails, According to a Certified Nurse MidwifeThe term self-managed abortion can be confusing. Experts discuss what it actually means, and doesn't mean.
Les mer »

House investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drugHouse investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drugA congressional investigation into the FDA's review process for an Alzheimer's treatment found that the agency 'deviated' from its standard procedures to approve the Aduhelm drug with inconsistent data.
Les mer »

FDA decision on experimental Alzheimer's drug expected this week | CNNFDA decision on experimental Alzheimer's drug expected this week | CNNThe US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental Alzheimer's drug lecanemab, according to Eisai and Biogen, the companies that make the drug.
Les mer »

Outdoor retail, new park among the projects to watch in Surprise next yearOutdoor retail, new park among the projects to watch in Surprise next yearMore restaurants, stores and family-oriented entertainment are on tap in Surprise.
Les mer »

Controversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportControversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportThe FDA's approval process of Alzheimer’s drug Aduhelm has been deemed “rife with irregularities,” according to a congressional investigation. Here are takeaways from the report.
Les mer »



Render Time: 2025-03-10 19:52:03